These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 1866472)

  • 1. Increased plasma levels of neuropeptide Y-like immunoreactivity and catecholamines in severe hypertension remain after treatment to normotension in man.
    Edvinsson L; Ekman R; Thulin T
    Regul Pept; 1991 Feb; 32(3):279-87. PubMed ID: 1866472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuropeptide Y-like immunoreactivity and hypertension.
    Erlinge D; Ekman R; Thulin T; Edvinsson L
    J Hypertens; 1992 Oct; 10(10):1221-5. PubMed ID: 1335004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevations of neuropeptide Y-like immunoreactivity and catecholamines in plasma on increased intracranial pressure in the pig.
    Rudehill A; Lundberg JM; Sollevi A; Hjemdahl P
    Acta Anaesthesiol Scand; 1987 Feb; 31(2):132-8. PubMed ID: 3564869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma neuropeptide Y-like immunoreactivity and catecholamines during various degrees of sympathetic activation in man.
    Pernow J; Lundberg JM; Kaijser L; Hjemdahl P; Theodorsson-Norheim E; Martinsson A; Pernow B
    Clin Physiol; 1986 Dec; 6(6):561-78. PubMed ID: 3466738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increases in plasma neuropeptide Y concentrations during sympathetic activation in man.
    Morris MJ; Russell AE; Kapoor V; Cain MD; Elliott JM; West MJ; Wing LM; Chalmers JP
    J Auton Nerv Syst; 1986 Oct; 17(2):143-9. PubMed ID: 3782722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alterations in circulating levels and cardiovascular tissue content of neuropeptide Y-like immunoreactivity during the development of deoxycorticosterone acetate-salt hypertension in the rat.
    Moreau P; de Champlain J; Yamaguchi N
    J Hypertens; 1992 Aug; 10(8):773-80. PubMed ID: 1325509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuropeptide Y in the sympathetic control of blood pressure in hypertensive subjects.
    Chalmers J; Morris M; Kapoor V; Cain M; Elliott J; Russell A; Pilowsky P; Minson J; West M; Wing L
    Clin Exp Hypertens A; 1989; 11 Suppl 1():59-66. PubMed ID: 2743605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated plasma concentration of neuropeptide Y and low level of circulating adrenaline in elderly asthmatics during rest and acute severe asthma.
    Dahlöf C; Dahlof P; Lundberg JM; Strömbom U
    Pulm Pharmacol; 1988; 1(1):3-6. PubMed ID: 2980285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alpha-adrenoceptor influence on plasma levels of neuropeptide Y-like immunoreactivity and catecholamines during rest and sympathoadrenal activation in humans.
    Pernow J; Lundberg JM; Kaijser L
    J Cardiovasc Pharmacol; 1988; 12(5):593-9. PubMed ID: 2468060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of vinblastine on neuropeptide Y levels in the sympathoadrenal system, bone marrow and thrombocytes of the rat.
    Hemsén A; Pernow J; Millberg BI; Lundberg JM
    Agents Actions; 1991 Nov; 34(3-4):429-38. PubMed ID: 1810152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuropeptide Y and sympathetic vascular control in man.
    Lundberg JM; Torssell L; Sollevi A; Pernow J; Theodorsson Norheim E; Anggård A; Hamberger B
    Regul Pept; 1985 Dec; 13(1):41-52. PubMed ID: 3841402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma neuropeptide Y and catecholamines in women and men with essential hypertension.
    Wocial B; Ignatowska-Switalska H; Pruszczyk P; Jedrusik P; Januszewicz A; Lapinski M; Januszewicz W; Zukowska-Grojec Z
    Blood Press; 1995 May; 4(3):143-7. PubMed ID: 7670647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuropeptide Y and alpha-adrenoceptor interactions in patients with essential hypertension.
    Wocial B; Ignatowska-Switalska H; Pruszczyk P; Zukowska-Grójec Z; Januszewicz W
    Mater Med Pol; 1994; 26(4):127-31. PubMed ID: 7666676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tetrodotoxin-sensitive release of adrenaline, noradrenaline and neuropeptide Y-like immunoreactivity in the pithed guinea-pig in the absence of electrical preganglionic nerve stimulation.
    Dahlöf C; Linton-Dahlöf P; Lundberg JM
    J Neurosci Methods; 1994 Jun; 52(2):215-8. PubMed ID: 7967724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relationship between age and venous plasma concentrations of noradrenaline, catecholamine metabolites, DOPA and neuropeptide Y-like immunoreactivity in normal human subjects.
    Hetland ML; Eldrup E; Bratholm P; Christensen NJ
    Scand J Clin Lab Invest; 1991 May; 51(3):219-24. PubMed ID: 1909048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevation of plasma neuropeptide Y-like immunoreactivity and noradrenaline during myocardial ischaemia in man.
    Ullman B; Franco-Cereceda A; Hulting J; Lundberg JM; Sollevi A
    J Intern Med; 1990 Dec; 228(6):583-9. PubMed ID: 2280235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma neuropeptide Y immunoreactivity influences left ventricular mass in pheochromocytoma.
    Kuch-Wocial A; Slubowska K; Kostrubiec M; Pasierski T; Januszewicz W; Switalska H; Wocial B; Pruszczyk P
    Clin Chim Acta; 2004 Jul; 345(1-2):43-7. PubMed ID: 15193976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stress-induced changes of circulating neuropeptide Y in the rat: comparison with catecholamines.
    Castagné V; Corder R; Gaillard R; Mormède P
    Regul Pept; 1987 Oct; 19(1-2):55-63. PubMed ID: 3317527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increase of plasma neuropeptide Y-like immunoreactivity following chronic hypoxia in the rat.
    Cheng JT; Chen CF; Shum AY; Wang JY; Chen HI
    Neurosci Lett; 1992 Jun; 140(2):211-4. PubMed ID: 1501780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence for co-transmitter role of neuropeptide Y in the pig spleen.
    Lundberg JM; Rudehill A; Sollevi A; Hamberger B
    Br J Pharmacol; 1989 Mar; 96(3):675-87. PubMed ID: 2566349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.